Canada issues guidance on creating drug eCTD Module 1 backbone using revised schema
This article was originally published in SRA
As of 30 September, Health Canada will begin accepting regulatory applications for drugs in electronic common technical format that have been built using a revised Canadian Module 1 schema (ie version 2.2)1.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.